PEPCID Side Effects

7018628-1 | Stevens-johnson Syndrome
on Sep 17, 2010 Male patient from JAPAN , 51 years of age, was treated with Pepcid (View Usage). Patient experienced the following unwanted or unexpected effects: stevens-johnson syndrome. Pepcid dosage: .

7013918-0 | Essential Thrombocythaemia, Sinusitis, Tubulointerstitial Nephritis
Patient was taking Pepcid (View Usage). Patient had the following side effects: essential thrombocythaemia, sinusitis (What is sinusitis?), tubulointerstitial nephritis on Sep 17, 2010 from JAPAN Additional patient health information: Female patient , 63 years of age, . Pepcid dosage: . During the same period patient was treated with DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6992684-9 | Pancytopenia, Stevens-johnson Syndrome, Viraemia
Adverse event was reported on Sep 07, 2010 by a Male patient taking Pepcid (View Usage) (Dosage: ) was diagnosed with pyrexia, cerebral haemorrhage, cytomegalovirus infection (What is cytomegalovirus infection?) and. Location: JAPAN , 61 years of age, After Pepcid was administered, patient had the following side effects: pancytopenia, stevens-johnson syndrome, viraemia. During the same period patient was treated with CEFDINIR (View Cefdinir Review and Cefdinir Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), ZONISAMIDE (View Zonisamide Review and Zonisamide Label ), GANCICLOVIR (View Ganciclovir Review and Ganciclovir Label ).

6988380-4 | Jejunal Ulcer
on Sep 06, 2010 Female patient from JAPAN , 66 years of age, was diagnosed with prophylaxis against gastrointestinal ulcer and was treated with Pepcid (View Usage). Patient experienced the following unwanted or unexpected effects: jejunal ulcer. Pepcid dosage: . Patient was hospitalized.


6985575-0 | Long Qt Syndrome, Torsade De Pointes
on Sep 07, 2010 Male patient from JAPAN , 80 years of age, was treated with Pepcid (View Usage). Patient had the following side effects: long qt syndrome, torsade de pointes. Pepcid dosage: . During the same period patient was treated with ANCARON (View Ancaron Review and Ancaron Label ), AMIODARONA (View Amiodarona Review and Amiodarona Label ).

6981110-1 | Multi-organ Failure, Toxic Epidermal Necrolysis
Patient was taking Pepcid (View Usage). After Pepcid was administered, patient had the following side effects: multi-organ failure, toxic epidermal necrolysis on Sep 07, 2010 from JAPAN Additional patient health information: Female patient , 65 years of age, weighting 156.5 lb, was diagnosed with gastritis, post procedural infection and. Pepcid dosage: . During the same period patient was treated with CEFZON (View Cefzon Review and Cefzon Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ), SIGMART (View Sigmart Review and Sigmart Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ).

6981098-3 | Thrombotic Microangiopathy
Adverse event was reported on Sep 02, 2010 by a Male patient taking Pepcid (View Usage) (Dosage: ) was diagnosed with liver transplant (What is liver transplant?) and. Location: JAPAN , 60 years of age, Patient experienced the following unwanted or unexpected effects: thrombotic microangiopathy. During the same period patient was treated with PROGRAF (View Prograf Review and Prograf Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), SULFAMETHOXAZOLE AND TRIMETHOPRIM (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), MEROPENEM (View Meropenem Review and Meropenem Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ).

6978962-8 | Multi-organ Failure, Toxic Epidermal Necrolysis
on Aug 31, 2010 Male patient from JAPAN , 72 years of age, was diagnosed with prophylaxis against gastrointestinal ulcer, infection prophylaxis, cardiovascular event prophylaxis, heart rate decreased and was treated with Pepcid (View Usage). Patient had the following side effects: multi-organ failure, toxic epidermal necrolysis. Pepcid dosage: . During the same period patient was treated with WYSTAL (View Wystal Review and Wystal Label ), CIMETIRAN (View Cimetiran Review and Cimetiran Label ), PANTOSIN (View Pantosin Review and Pantosin Label ), DIGOSIN (View Digosin Review and Digosin Label ), ONOACT (View Onoact Review and Onoact Label ).

6968718-4 | Multi-organ Failure, Toxic Epidermal Necrolysis
on Aug 26, 2010 Female patient from JAPAN , 65 years of age, was treated with Pepcid (View Usage). After Pepcid was administered, patient had the following side effects: multi-organ failure, toxic epidermal necrolysis. Pepcid dosage: . During the same period patient was treated with CEFZON (View Cefzon Review and Cefzon Label ).

6965751-3 | Stevens-johnson Syndrome
Patient was taking Pepcid (View Usage). Patient experienced the following unwanted or unexpected effects: stevens-johnson syndrome on Aug 27, 2010 from JAPAN Additional patient health information: Male patient , 71 years of age, weighting 81.57 lb, was diagnosed with gastric ulcer, oral infection and. Pepcid dosage: . During the same period patient was treated with FLUMARIN (View Flumarin Review and Flumarin Label ), DALACIN S (View Dalacin S Review and Dalacin S Label ). Patient was hospitalized.

6961024-3 | Cerebral Atrophy, Cerebral Infarction, Colitis Ulcerative, Convulsion, Extranodal Marginal Zone B-cell Lymphoma (malt Type), Gastric Cancer Stage Ii, Status Epilepticus, Vitamin B6 Decreased
Adverse event was reported on Aug 27, 2010 by a Male patient taking Pepcid (View Usage) (Dosage: ) . Location: JAPAN , 89 years of age, Patient had the following side effects: cerebral atrophy, cerebral infarction, colitis ulcerative, convulsion, extranodal marginal zone b-cell lymphoma (malt type), gastric cancer stage ii, status epilepticus, vitamin b6 decreased. During the same period patient was treated with UNIPHYL (View Uniphyl Review and Uniphyl Label ), OMEPRAL (View Omepral Review and Omepral Label ), SALAZOPYRIN (View Salazopyrin Review and Salazopyrin Label ). Patient was hospitalized.

6958553-5 | Duodenal Ulcer, Oesophagitis
on Aug 24, 2010 Female patient from JAPAN , 65 years of age, was treated with Pepcid (View Usage). After Pepcid was administered, patient had the following side effects: duodenal ulcer, oesophagitis. Pepcid dosage: . During the same period patient was treated with AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), REBAMIPIDE (View Rebamipide Review and Rebamipide Label ). Patient was hospitalized.

6955954-6 | Skin Test, Stevens-johnson Syndrome
on Aug 20, 2010 Female patient from FRANCE , 31 years of age, was diagnosed with gastritis, migraine (What is migraine?), contraception and was treated with Pepcid (View Usage). Patient experienced the following unwanted or unexpected effects: skin test, stevens-johnson syndrome. Pepcid dosage: . During the same period patient was treated with LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ), KETOPROFEN (View Ketoprofen Review and Ketoprofen Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), ETHINYL ESTRADIOL AND GESTODENE (View Ethinyl Estradiol And Gestodene Review and Ethinyl Estradiol And Gestodene Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), ELETRIPTAN HYDROBROMIDE (View Eletriptan Hydrobromide Review and Eletriptan Hydrobromide Label ). Patient was hospitalized.

6945645-X | Anaphylactic Shock
Patient was taking Pepcid (View Usage). Patient had the following side effects: anaphylactic shock on Aug 19, 2010 from JAPAN Additional patient health information: Female patient , 27 years of age, . Pepcid dosage: . During the same period patient was treated with SOLDEM 3 (View Soldem 3 Review and Soldem 3 Label ). Patient was hospitalized.

6945636-9 | Rhabdomyolysis
Adverse event was reported on Aug 18, 2010 by a Male patient taking Pepcid (View Usage) (Dosage: ) was diagnosed with prophylaxis and. Location: JAPAN , 62 years of age, weighting 138.9 lb, After Pepcid was administered, patient had the following side effects: rhabdomyolysis. During the same period patient was treated with UNASYN (View Unasyn Review and Unasyn Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), SODIUM CHLORIDE (View Sodium Chloride Review and Sodium Chloride Label ), ATROPINE SULFATE (View Atropine Sulfate Review and Atropine Sulfate Label ), MUSCULAX (View Musculax Review and Musculax Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), LACTEC (View Lactec Review and Lactec Label ).

6943010-2 | Skin Test, Stevens-johnson Syndrome
on Aug 20, 2010 Female patient from FRANCE , 31 years of age, was diagnosed with gastritis, migraine (What is migraine?), contraception and was treated with Pepcid (View Usage). Patient experienced the following unwanted or unexpected effects: skin test, stevens-johnson syndrome. Pepcid dosage: . During the same period patient was treated with LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ), KETOPROFEN (View Ketoprofen Review and Ketoprofen Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), ETHINYL ESTRADIOL AND GESTODENE (View Ethinyl Estradiol And Gestodene Review and Ethinyl Estradiol And Gestodene Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), ELETRIPTAN HYDROBROMIDE (View Eletriptan Hydrobromide Review and Eletriptan Hydrobromide Label ). Patient was hospitalized.

6934113-7 | Blood Pressure Decreased
on Aug 10, 2010 Female patient from JAPAN , 31 years of age, weighting 103.6 lb, was treated with Pepcid (View Usage). Patient had the following side effects: blood pressure decreased. Pepcid dosage: . During the same period patient was treated with BUPIVACAINE HYDROCHLORIDE (View Bupivacaine Hydrochloride Review and Bupivacaine Hydrochloride Label ), MORPHINE HYDROCHLORIDE (View Morphine Hydrochloride Review and Morphine Hydrochloride Label ).

6926492-1 | Rhabdomyolysis
Patient was taking Pepcid (View Usage). After Pepcid was administered, patient had the following side effects: rhabdomyolysis on Aug 11, 2010 from JAPAN Additional patient health information: Male patient , 62 years of age, weighting 138.9 lb, was diagnosed with prophylaxis and. Pepcid dosage: . During the same period patient was treated with UNASYN (View Unasyn Review and Unasyn Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), NITROUS OXIDE (View Nitrous Oxide Review and Nitrous Oxide Label ), ATROPINE SULFATE (View Atropine Sulfate Review and Atropine Sulfate Label ), MUSCULAX (View Musculax Review and Musculax Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), LACTEC (View Lactec Review and Lactec Label ).

6921624-3 | Gastrointestinal Perforation
Adverse event was reported on Aug 04, 2010 by a Male patient taking Pepcid (View Usage) (Dosage: ) . Location: JAPAN , 72 years of age, Patient experienced the following unwanted or unexpected effects: gastrointestinal perforation. During the same period patient was treated with SODIUM BICARBONATE (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ), CARBENIN (View Carbenin Review and Carbenin Label ).

6921613-9 | Multi-organ Failure, Toxic Epidermal Necrolysis
on Aug 02, 2010 Male patient from JAPAN , 72 years of age, was diagnosed with prophylaxis against gastrointestinal ulcer, infection prophylaxis, cardiovascular event prophylaxis, heart rate decreased and was treated with Pepcid (View Usage). Patient had the following side effects: multi-organ failure, toxic epidermal necrolysis. Pepcid dosage: . During the same period patient was treated with WYSTAL (View Wystal Review and Wystal Label ), CIMETIRAN (View Cimetiran Review and Cimetiran Label ), PANTOSIN (View Pantosin Review and Pantosin Label ), DIGOSIN (View Digosin Review and Digosin Label ), ONOACT (View Onoact Review and Onoact Label ).

6921593-6 | Cerebral Atrophy, Cerebral Infarction, Colitis Ulcerative, Convulsion, Extranodal Marginal Zone B-cell Lymphoma (malt Type), Gastric Cancer Stage Ii, Vitamin B6 Decreased
on Aug 05, 2010 Male patient from JAPAN , 89 years of age, was treated with Pepcid (View Usage). After Pepcid was administered, patient had the following side effects: cerebral atrophy, cerebral infarction, colitis ulcerative, convulsion, extranodal marginal zone b-cell lymphoma (malt type), gastric cancer stage ii, vitamin b6 decreased. Pepcid dosage: . During the same period patient was treated with UNIPHYL (View Uniphyl Review and Uniphyl Label ), OMEPRAL (View Omepral Review and Omepral Label ), SALAZOPYRIN (View Salazopyrin Review and Salazopyrin Label ). Patient was hospitalized.

6919609-6 | Rhabdomyolysis
Patient was taking Pepcid (View Usage). Patient experienced the following unwanted or unexpected effects: rhabdomyolysis on Aug 03, 2010 from JAPAN Additional patient health information: Male patient , 62 years of age, weighting 138.9 lb, was diagnosed with prophylaxis and. Pepcid dosage: . During the same period patient was treated with UNASYN (View Unasyn Review and Unasyn Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), NITROUS OXIDE (View Nitrous Oxide Review and Nitrous Oxide Label ), ATROPINE SULFATE (View Atropine Sulfate Review and Atropine Sulfate Label ), MUSCULAX (View Musculax Review and Musculax Label ).

6912344-X | Deep Vein Thrombosis
Adverse event was reported on Jul 30, 2010 by a Female patient taking Pepcid (View Usage) (Dosage: ) was diagnosed with oedema peripheral, hypertension, back pain (What is back pain?), muscle spasms, gastritis and. Location: JAPAN , 37 years of age, Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?). During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), CELCOX (View Celcox Review and Celcox Label ), NORVASC (View Norvasc Review and Norvasc Label ), KEISHI KA SHAKUYAKU DAIO TO (View Keishi-ka-shakuyaku-daio-to Review and Keishi-ka-shakuyaku-daio-to Label ), MUCOSTA (View Mucosta Review and Mucosta Label ).

6912339-6 | Gastric Ulcer
on Aug 02, 2010 Female patient from JAPAN , 73 years of age, was diagnosed with gastritis and was treated with Pepcid (View Usage). After Pepcid was administered, patient had the following side effects: gastric ulcer. Pepcid dosage: . Patient was hospitalized.

6911119-5 | Anaemia Megaloblastic, Gastrointestinal Haemorrhage, Lower Respiratory Tract Inflammation
on Jul 16, 2010 Male patient from JAPAN , child 9 years of age, was diagnosed with gastrointestinal haemorrhage and was treated with Pepcid (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia megaloblastic, gastrointestinal haemorrhage, lower respiratory tract inflammation. Pepcid dosage: . During the same period patient was treated with PHENOBARBITAL (View Phenobarbital Review and Phenobarbital Label ). Patient was hospitalized.

6909626-4 | Rhabdomyolysis
Patient was taking Pepcid (View Usage). Patient had the following side effects: rhabdomyolysis on Jul 28, 2010 from JAPAN Additional patient health information: Male patient , 50 years of age, . Pepcid dosage: . During the same period patient was treated with UNASYN (View Unasyn Review and Unasyn Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), NITROUS OXIDE (View Nitrous Oxide Review and Nitrous Oxide Label ).

6896436-X | Venous Thrombosis Limb
Adverse event was reported on Jul 14, 2010 by a Female patient taking Pepcid (View Usage) (Dosage: ) . Location: JAPAN , 36 years of age, After Pepcid was administered, patient had the following side effects: venous thrombosis limb. During the same period patient was treated with CELCOX (View Celcox Review and Celcox Label ), NORVASC (View Norvasc Review and Norvasc Label ), KEISHI KA SHAKUYAKU DAIO TO (View Keishi-ka-shakuyaku-daio-to Review and Keishi-ka-shakuyaku-daio-to Label ).

6895271-6 | Blood Pressure Decreased
on Jul 21, 2010 Female patient from JAPAN , 31 years of age, weighting 103.6 lb, was treated with Pepcid (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased. Pepcid dosage: . During the same period patient was treated with BUPIVACAINE HYDROCHLORIDE (View Bupivacaine Hydrochloride Review and Bupivacaine Hydrochloride Label ), MORPHINE HYDROCHLORIDE (View Morphine Hydrochloride Review and Morphine Hydrochloride Label ).

6888134-3 | Deep Vein Thrombosis
on Jul 20, 2010 Female patient from JAPAN , 37 years of age, was diagnosed with back pain (What is back pain?) and was treated with Pepcid (View Usage). Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?). Pepcid dosage: . During the same period patient was treated with CELCOX (View Celcox Review and Celcox Label ), NORVASC (View Norvasc Review and Norvasc Label ), KEISHI KA SHAKUYAKU DAIO TO (View Keishi-ka-shakuyaku-daio-to Review and Keishi-ka-shakuyaku-daio-to Label ), MUCOSTA (View Mucosta Review and Mucosta Label ).

6885286-6 | Abdominal Pain, Chest Discomfort, Hypertension
Patient was taking Pepcid (View Usage). After Pepcid was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), chest discomfort, hypertension on Jul 29, 2010 from UNITED STATES Additional patient health information: Male patient , 59 years of age, weighting 183.0 lb, was diagnosed with gastrooesophageal reflux disease and. Pepcid dosage: 20 Mg Once Iv Bolus. Patient was hospitalized.

6878475-8 | Blood Pressure Decreased
Adverse event was reported on Jul 21, 2010 by a Female patient taking Pepcid (View Usage) (Dosage: ) . Location: JAPAN , 31 years of age, weighting 103.6 lb, Patient experienced the following unwanted or unexpected effects: blood pressure decreased. During the same period patient was treated with BUPIVACAINE HYDROCHLORIDE (View Bupivacaine Hydrochloride Review and Bupivacaine Hydrochloride Label ), MORPHINE HYDROCHLORIDE (View Morphine Hydrochloride Review and Morphine Hydrochloride Label ).

6864247-7 | Multi-organ Failure, Toxic Epidermal Necrolysis
on Jul 14, 2010 Male patient from JAPAN , 72 years of age, was treated with Pepcid (View Usage). Patient had the following side effects: multi-organ failure, toxic epidermal necrolysis. Pepcid dosage: .

6860814-5 | Liver Disorder
on Jul 14, 2010 Male patient from JAPAN , 54 years of age, was treated with Pepcid (View Usage). After Pepcid was administered, patient had the following side effects: liver disorder. Pepcid dosage: . During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ).

6836327-3 | Anaemia Megaloblastic, Gastrointestinal Haemorrhage, Lower Respiratory Tract Inflammation
Patient was taking Pepcid (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia megaloblastic, gastrointestinal haemorrhage, lower respiratory tract inflammation on Jul 06, 2010 from JAPAN Additional patient health information: Male patient , child 9 years of age, was diagnosed with gastrointestinal haemorrhage and. Pepcid dosage: . During the same period patient was treated with PHENOBARBITAL (View Phenobarbital Review and Phenobarbital Label ). Patient was hospitalized.

6831916-4 | Cholangitis, Liver Abscess, Lung Disorder, Portal Vein Thrombosis
Adverse event was reported on Jun 10, 2010 by a Female patient taking Pepcid (View Usage) (Dosage: ) . Location: JAPAN , 36 years of age, Patient had the following side effects: cholangitis, liver abscess, lung disorder, portal vein thrombosis. During the same period patient was treated with FUTHAN (View Futhan Review and Futhan Label ), MIRACLID (View Miraclid Review and Miraclid Label ), MEROPEN (View Meropen Review and Meropen Label ).

6831907-3 | Tachycardia, Ventricular Fibrillation, Ventricular Tachycardia
on Jul 01, 2010 Male patient from JAPAN , 86 years of age, was treated with Pepcid (View Usage). After Pepcid was administered, patient had the following side effects: tachycardia, ventricular fibrillation, ventricular tachycardia. Pepcid dosage: .

6823085-1 | Lip Oedema, Oropharyngeal Pain, Pharyngeal Erythema, Pyrexia, Rash Maculo-papular, Tongue Oedema
on Jun 29, 2010 Female patient from JAPAN , 30 years of age, weighting 99.21 lb, was diagnosed with gastritis prophylaxis, back pain (What is back pain?) and was treated with Pepcid (View Usage). Patient experienced the following unwanted or unexpected effects: lip oedema, oropharyngeal pain, pharyngeal erythema, pyrexia, rash maculo-papular, tongue oedema. Pepcid dosage: . During the same period patient was treated with CELECOX (View Celecox Review and Celecox Label ), GASLON N (View Gaslon N Review and Gaslon N Label ). Patient was hospitalized.

6815800-8 | Ventricular Fibrillation, Ventricular Tachycardia
Patient was taking Pepcid (View Usage). Patient had the following side effects: ventricular fibrillation, ventricular tachycardia on Jun 25, 2010 from JAPAN Additional patient health information: Male patient , 86 years of age, . Pepcid dosage: .

6801616-5 | Ventricular Fibrillation, Ventricular Tachycardia
Adverse event was reported on Jun 21, 2010 by a Male patient taking Pepcid (View Usage) (Dosage: ) . Location: JAPAN , 86 years of age, After Pepcid was administered, patient had the following side effects: ventricular fibrillation, ventricular tachycardia.

6782768-2 | Cholangitis, Liver Abscess, Lung Disorder, Portal Vein Thrombosis
on Jun 10, 2010 Female patient from JAPAN , 36 years of age, was treated with Pepcid (View Usage). Patient experienced the following unwanted or unexpected effects: cholangitis, liver abscess, lung disorder, portal vein thrombosis. Pepcid dosage: . During the same period patient was treated with FUTHAN (View Futhan Review and Futhan Label ), MIRACLID (View Miraclid Review and Miraclid Label ), MEROPEN (View Meropen Review and Meropen Label ).

6782111-9 | Therapeutic Agent Toxicity
on Jun 10, 2010 Female patient from JAPAN , child 9 years of age, was treated with Pepcid (View Usage). Patient had the following side effects: therapeutic agent toxicity. Pepcid dosage: . During the same period patient was treated with AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), CHLORPROMAZINE HYDROCHLORIDE (View Chlorpromazine Hydrochloride Review and Chlorpromazine Hydrochloride Label ).

6775439-X | Lip Oedema, Oropharyngeal Pain, Pharyngeal Erythema, Pyrexia, Rash Maculo-papular, Tongue Oedema
Patient was taking Pepcid (View Usage). After Pepcid was administered, patient had the following side effects: lip oedema, oropharyngeal pain, pharyngeal erythema, pyrexia, rash maculo-papular, tongue oedema on Jun 11, 2010 from JAPAN Additional patient health information: Female patient , 30 years of age, weighting 99.21 lb, was diagnosed with gastritis prophylaxis, back pain (What is back pain?) and. Pepcid dosage: . During the same period patient was treated with CELECOX (View Celecox Review and Celecox Label ), GASLON N (View Gaslon N Review and Gaslon N Label ). Patient was hospitalized.

6770182-5 | Cerebral Haemorrhage, Pneumonia, Pneumonia Aspiration, Tooth Disorder, Vitamin K Deficiency
Adverse event was reported on May 19, 2010 by a Male patient taking Pepcid (View Usage) (Dosage: ) . Location: JAPAN , 71 years of age, weighting 74.96 lb, Patient experienced the following unwanted or unexpected effects: cerebral haemorrhage, pneumonia (What is pneumonia?), pneumonia aspiration, tooth disorder (What is tooth disorder?), vitamin k deficiency. During the same period patient was treated with PIPERACILLIN (View Piperacillin Review and Piperacillin Label ), SODIUM CHLORIDE (View Sodium Chloride Review and Sodium Chloride Label ), TRIHEXYPHENIDYL HYDROCHLORIDE (View Trihexyphenidyl Hydrochloride Review and Trihexyphenidyl Hydrochloride Label ), VALSARTAN (View Valsartan Review and Valsartan Label ). Patient was hospitalized.

6762615-5 | Hepatic Neoplasm Malignant, Large Intestine Carcinoma
on May 07, 2010 Male patient from JAPAN , 70 years of age, weighting 136.7 lb, was diagnosed with malaise and was treated with Pepcid (View Usage). Patient had the following side effects: hepatic neoplasm malignant, large intestine carcinoma. Pepcid dosage: . During the same period patient was treated with HOCHU EKKI TO (View Hochu-ekki-to Review and Hochu-ekki-to Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), IMIDAPRIL HYDROCHLORIDE (View Imidapril Hydrochloride Review and Imidapril Hydrochloride Label ), URSODIOL (View Ursodiol Review and Ursodiol Label ). Patient was hospitalized.

6752007-7 | Shock
on May 25, 2010 Female patient from JAPAN , 69 years of age, weighting 149.9 lb, was diagnosed with ovarian cancer and was treated with Pepcid (View Usage). After Pepcid was administered, patient had the following side effects: shock. Pepcid dosage: . During the same period patient was treated with DECADRON (View Decadron Review and Decadron Label ), KYTRIL (View Kytril Review and Kytril Label ), RAMELTEON (View Ramelteon Review and Ramelteon Label ), PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ), VENA (View Vena Review and Vena Label ). Patient was hospitalized.

6744302-2 | Lip Oedema, Oropharyngeal Pain, Pharyngeal Erythema, Pyrexia, Rash Maculo-papular, Tongue Oedema
Patient was taking Pepcid (View Usage). Patient experienced the following unwanted or unexpected effects: lip oedema, oropharyngeal pain, pharyngeal erythema, pyrexia, rash maculo-papular, tongue oedema on May 18, 2010 from JAPAN Additional patient health information: Female patient , 30 years of age, weighting 99.21 lb, was diagnosed with back pain (What is back pain?) and. Pepcid dosage: . During the same period patient was treated with CELECOX (View Celecox Review and Celecox Label ), GASLON N (View Gaslon N Review and Gaslon N Label ). Patient was hospitalized.

6742637-0 | Cerebral Haemorrhage, Pneumonia, Pneumonia Aspiration, Tooth Disorder, Vitamin K Deficiency
Adverse event was reported on May 19, 2010 by a Male patient taking Pepcid (View Usage) (Dosage: ) . Location: JAPAN , 71 years of age, weighting 74.96 lb, Patient had the following side effects: cerebral haemorrhage, pneumonia (What is pneumonia?), pneumonia aspiration, tooth disorder (What is tooth disorder?), vitamin k deficiency. During the same period patient was treated with PIPERACILLIN (View Piperacillin Review and Piperacillin Label ), SODIUM CHLORIDE (View Sodium Chloride Review and Sodium Chloride Label ), TRIHEXYPHENIDYL HYDROCHLORIDE (View Trihexyphenidyl Hydrochloride Review and Trihexyphenidyl Hydrochloride Label ), VALSARTAN (View Valsartan Review and Valsartan Label ). Patient was hospitalized.

6742235-9 | Hepatic Neoplasm Malignant, Large Intestine Carcinoma
on May 21, 2010 Male patient from JAPAN , 70 years of age, weighting 136.7 lb, was diagnosed with malaise and was treated with Pepcid (View Usage). After Pepcid was administered, patient had the following side effects: hepatic neoplasm malignant, large intestine carcinoma. Pepcid dosage: . During the same period patient was treated with HOCHU EKKI TO (View Hochu-ekki-to Review and Hochu-ekki-to Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), IMIDAPRIL HYDROCHLORIDE (View Imidapril Hydrochloride Review and Imidapril Hydrochloride Label ), URSODIOL (View Ursodiol Review and Ursodiol Label ). Patient was hospitalized.

6740291-5 | Lip Oedema, Oropharyngeal Pain, Pharyngeal Erythema, Pyrexia, Rash Maculo-papular, Tongue Oedema
on May 18, 2010 Female patient from JAPAN , 30 years of age, weighting 99.21 lb, was diagnosed with back pain (What is back pain?) and was treated with Pepcid (View Usage). Patient experienced the following unwanted or unexpected effects: lip oedema, oropharyngeal pain, pharyngeal erythema, pyrexia, rash maculo-papular, tongue oedema. Pepcid dosage: . During the same period patient was treated with CELECOX (View Celecox Review and Celecox Label ), GASLON N (View Gaslon N Review and Gaslon N Label ). Patient was hospitalized.

6736440-5 | Systemic Lupus Erythematosus
Patient was taking Pepcid (View Usage). Patient had the following side effects: systemic lupus erythematosus on May 14, 2010 from JAPAN Additional patient health information: Male patient , 93 years of age, . Pepcid dosage: . During the same period patient was treated with ANCARON (View Ancaron Review and Ancaron Label ), SIGMART (View Sigmart Review and Sigmart Label ).